Sofinnova Investments’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.3K Buy
+1,610
New +$38.1K ﹤0.01% 74
2022
Q1
Sell
-392,712
Closed -$6.44M 79
2021
Q4
$6.44M Sell
392,712
-17,907
-4% -$373K 0.38% 49
2021
Q3
$11.9M Buy
+410,619
New +$13.7M 0.71% 34
2020
Q4
Sell
-151,902
Closed -$7.08M 81
2020
Q3
$7.08M Sell
151,902
-147,832
-49% -$5.08M 0.52% 31
2020
Q2
$10.8M Buy
299,734
+249,745
+500% +$9.2M 0.68% 33
2020
Q1
$1.77M Sell
49,989
-57,563
-54% -$2.36M 0.16% 55
2019
Q4
$4.89M Sell
107,552
-80,886
-43% -$2.94M 0.35% 44
2019
Q3
$4.67M Buy
188,438
+381
+0.2% +$9.55K 0.42% 45
2019
Q2
$4.14M Buy
+188,057
New +$3.45M 0.38% 44

Other funds holding ZYME

Sofinnova Investments's ZYME Position: Q1 2026 in Review

Sofinnova Investments opened a new position in Zymeworks (ZYME) in Q1 2026: 1,610 shares worth $40.3K. The stake represents ﹤0.01% of the portfolio and ranks #74 among its holdings. This is a return to the name: Sofinnova Investments previously reported a position in ZYME as recently as Q4 2021.

Sofinnova Investments first reported a position in ZYME in Q2 2019 and has held it in 9 quarters since. The position peaked at $11.9M in Q3 2021. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Sofinnova Investments held 1,610 shares of Zymeworks worth $40.3K as of Q1 2026.
  • Zymeworks was a new Sofinnova Investments position in Q1 2026.
  • Zymeworks made up ﹤0.01% of Sofinnova Investments's portfolio in Q1 2026, its #74 holding.
  • Sofinnova Investments first reported a position in Zymeworks in Q2 2019 and has held it in 9 quarters since.
  • Sofinnova Investments's Zymeworks position peaked at $11.9M in Q3 2021.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Sofinnova Investments's 13F filing for Q1 2026, filed 15 May 2026.